US Stock MarketDetailed Quotes

Apellis Pharmaceuticals (APLS)

Watchlist
  • 20.530
  • +0.200+0.98%
Close Jan 15 16:00 ET
  • 20.530
  • 0.0000.00%
Post 20:01 ET
2.60BMarket Cap57.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apellis Pharmaceuticals (APLS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
132.98%458.58M
-10.61%178.49M
-3.21%166.8M
97.02%781.37M
45.19%212.53M
78.29%196.83M
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
Operating revenue
132.98%458.58M
-10.61%178.49M
-3.21%166.8M
97.02%781.37M
45.19%212.53M
78.29%196.83M
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
Cost of revenue
-26.90%24.53M
-41.01%13.63M
70.02%34.36M
101.20%117.72M
105.18%40.86M
49.74%33.56M
175.69%23.1M
158.79%20.21M
938.15%58.51M
580.75%19.91M
Gross profit
165.84%434.05M
-6.64%164.87M
-12.94%132.44M
96.30%663.64M
35.75%171.67M
85.56%163.27M
103.93%176.59M
310.71%152.12M
384.45%338.08M
540.72%126.47M
Operating expense
0.15%210.86M
-3.82%198.15M
0.73%215.77M
-3.11%828.62M
-6.23%197.84M
-6.45%210.55M
-0.48%206.03M
0.98%214.21M
28.72%855.2M
14.80%210.98M
Selling and administrative expenses
16.96%142.68M
2.39%131.14M
-0.12%129.35M
0.05%501.05M
-14.27%121.48M
-16.25%121.98M
15.00%128.08M
26.85%129.51M
80.69%500.82M
67.96%141.7M
Research and development costs
-23.01%68.19M
-14.02%67.02M
2.03%86.42M
-7.57%327.57M
10.21%76.35M
11.52%88.57M
-18.51%77.95M
-23.02%84.7M
-8.48%354.39M
-30.32%69.28M
Operating profit
572.05%223.18M
-13.05%-33.29M
-34.21%-83.33M
68.10%-164.98M
69.04%-26.16M
65.51%-47.28M
75.55%-29.44M
64.54%-62.09M
13.03%-517.12M
48.48%-84.52M
Net non-operating interest income expense
28.41%-6.9M
-38.38%-8.55M
-129.01%-8.39M
-219.36%-27.62M
-185.14%-8.14M
-315.47%-9.64M
-361.17%-6.18M
-71.54%-3.66M
63.53%-8.65M
9.77%-2.85M
Non-operating interest income
51.47%4.38M
-18.12%2.61M
-19.53%2.66M
-38.98%12.77M
-25.33%3.4M
-42.09%2.89M
-46.95%3.18M
-38.75%3.3M
134.83%20.93M
-0.59%4.55M
Non-operating interest expense
-10.00%11.28M
19.16%11.15M
58.59%11.05M
36.54%40.39M
55.82%11.53M
71.44%12.53M
27.49%9.36M
-7.46%6.97M
-9.33%29.58M
-4.34%7.4M
Other net income (expense)
-47.14%37K
107.58%146K
66.93%-165K
-466.57%-4.12M
-905.94%-1.77M
111.61%70K
-2,955.56%-1.93M
-80.14%-499K
97.81%-727K
189.02%219K
Special income (charges)
--0
--0
----
---1.95M
--0
--0
---1.95M
----
--0
--0
-Less:Other special charges
----
----
----
--1.95M
--0
----
--1.95M
----
----
----
Other non- operating income (expenses)
-47.14%37K
508.33%146K
66.93%-165K
-198.49%-2.17M
-905.94%-1.77M
111.61%70K
138.10%24K
-80.14%-499K
-152.43%-727K
189.02%219K
Income before tax
480.48%216.32M
-11.03%-41.69M
-38.69%-91.88M
62.64%-196.72M
58.62%-36.07M
59.39%-56.85M
69.19%-37.54M
62.67%-66.25M
19.19%-526.5M
47.96%-87.15M
Income tax
1.69%602K
308.77%466K
100.59%341K
-45.50%1.16M
-79.90%286K
154.08%592K
-41.24%114K
-39.72%170K
218.68%2.13M
196.74%1.42M
Net income
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
Net income continuous Operations
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
Minority interest income
Net income attributable to the parent company
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
Basic earnings per share
471.74%1.71
-10.00%-0.33
-37.04%-0.74
64.04%-1.6
60.27%-0.29
60.68%-0.46
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
Diluted earnings per share
463.04%1.67
-10.00%-0.33
-37.04%-0.74
64.04%-1.6
60.27%-0.29
60.68%-0.46
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 132.98%458.58M-10.61%178.49M-3.21%166.8M97.02%781.37M45.19%212.53M78.29%196.83M110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M
Operating revenue 132.98%458.58M-10.61%178.49M-3.21%166.8M97.02%781.37M45.19%212.53M78.29%196.83M110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M
Cost of revenue -26.90%24.53M-41.01%13.63M70.02%34.36M101.20%117.72M105.18%40.86M49.74%33.56M175.69%23.1M158.79%20.21M938.15%58.51M580.75%19.91M
Gross profit 165.84%434.05M-6.64%164.87M-12.94%132.44M96.30%663.64M35.75%171.67M85.56%163.27M103.93%176.59M310.71%152.12M384.45%338.08M540.72%126.47M
Operating expense 0.15%210.86M-3.82%198.15M0.73%215.77M-3.11%828.62M-6.23%197.84M-6.45%210.55M-0.48%206.03M0.98%214.21M28.72%855.2M14.80%210.98M
Selling and administrative expenses 16.96%142.68M2.39%131.14M-0.12%129.35M0.05%501.05M-14.27%121.48M-16.25%121.98M15.00%128.08M26.85%129.51M80.69%500.82M67.96%141.7M
Research and development costs -23.01%68.19M-14.02%67.02M2.03%86.42M-7.57%327.57M10.21%76.35M11.52%88.57M-18.51%77.95M-23.02%84.7M-8.48%354.39M-30.32%69.28M
Operating profit 572.05%223.18M-13.05%-33.29M-34.21%-83.33M68.10%-164.98M69.04%-26.16M65.51%-47.28M75.55%-29.44M64.54%-62.09M13.03%-517.12M48.48%-84.52M
Net non-operating interest income expense 28.41%-6.9M-38.38%-8.55M-129.01%-8.39M-219.36%-27.62M-185.14%-8.14M-315.47%-9.64M-361.17%-6.18M-71.54%-3.66M63.53%-8.65M9.77%-2.85M
Non-operating interest income 51.47%4.38M-18.12%2.61M-19.53%2.66M-38.98%12.77M-25.33%3.4M-42.09%2.89M-46.95%3.18M-38.75%3.3M134.83%20.93M-0.59%4.55M
Non-operating interest expense -10.00%11.28M19.16%11.15M58.59%11.05M36.54%40.39M55.82%11.53M71.44%12.53M27.49%9.36M-7.46%6.97M-9.33%29.58M-4.34%7.4M
Other net income (expense) -47.14%37K107.58%146K66.93%-165K-466.57%-4.12M-905.94%-1.77M111.61%70K-2,955.56%-1.93M-80.14%-499K97.81%-727K189.02%219K
Special income (charges) --0--0-------1.95M--0--0---1.95M------0--0
-Less:Other special charges --------------1.95M--0------1.95M------------
Other non- operating income (expenses) -47.14%37K508.33%146K66.93%-165K-198.49%-2.17M-905.94%-1.77M111.61%70K138.10%24K-80.14%-499K-152.43%-727K189.02%219K
Income before tax 480.48%216.32M-11.03%-41.69M-38.69%-91.88M62.64%-196.72M58.62%-36.07M59.39%-56.85M69.19%-37.54M62.67%-66.25M19.19%-526.5M47.96%-87.15M
Income tax 1.69%602K308.77%466K100.59%341K-45.50%1.16M-79.90%286K154.08%592K-41.24%114K-39.72%170K218.68%2.13M196.74%1.42M
Net income 475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M
Net income continuous Operations 475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M
Minority interest income
Net income attributable to the parent company 475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M
Basic earnings per share 471.74%1.71-10.00%-0.33-37.04%-0.7464.04%-1.660.27%-0.2960.68%-0.4670.59%-0.365.38%-0.5427.64%-4.4551.33%-0.73
Diluted earnings per share 463.04%1.67-10.00%-0.33-37.04%-0.7464.04%-1.660.27%-0.2960.68%-0.4670.59%-0.365.38%-0.5427.64%-4.4551.33%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -